Please wait while the formulary information is being retrieved.
UTIBRON NEOHALER (indacaterol maleate/glycopyrrolate)
- Bronchospasm prevention with COPD
- Prevention of bronchospasm with chronic bronchitis
- Prevention of bronchospasms with emphysema
27.5 mcg-15.6 mcg capsule with inhalation device
- Inhale the contents of one capsule by inhalation route 2 times per day in the morning and evening
Bronchospasm prevention with COPD
- Inhale the contents of one capsule by inhalation route 2 times per day in the morning and evening
Prevention of bronchospasm with chronic bronchitis
- Inhale the contents of one capsule by inhalation route 2 times per day in the morning and evening
Prevention of bronchospasms with emphysema
- Inhale the contents of one capsule by inhalation route 2 times per day in the morning and evening
- None
Contraindicated
- bromocriptine
- cabergoline
- Cafergot
- Compound 347
- Cycloset
- D.h.e.45
- dihydroergotamine
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- isoflurane
- methylergonovine
- Migergot
- Migranal
- Parlodel
- pramlintide
- sevoflurane
- Sojourn
- Symlinpen 120
- Symlinpen 60
- Terrell
- Ultane
Severe
Moderate
- Adasuve
- chlorpromazine
- Compazine
- Compro
- fluphenazine decanoate
- fluphenazine HCl
- Haldol
- Haldol Decanoate
- haloperidol
- haloperidol decanoate
- haloperidol lactate
- K-tab
- Klor-con
- Klor-con 10
- Klor-con M10
- Klor-con M15
- Klor-con M20
- loxapine
- loxapine succinate
- Loxitane
- Medi-lyte
- perphenazine
- perphenazine-amitriptyline
- Phenadoz
- Phenergan
- potassium chloride
- potassium citrate
- potassium Cl-calcium phos-mag
- prochlorperazine
- prochlorperazine Edisylate
- prochlorperazine maleate
- promethazine
- Promethazine Vc
- Promethazine Vc-codeine
- promethazine-codeine
- promethazine-DM
- promethazine-phenyleph-codeine
- promethazine-phenylephrine
- Promethegan
- sodium Cl-potassium chloride
- Thermotabs
- thioridazine
- trifluoperazine
- Urocit-k 10
- Urocit-k 15
- Urocit-k 5
- Acutely deteriorating asthma
Contraindicated
- Congenital long QT syndrome
- Hypokalemia
- Prolonged QT interval
Severe
Moderate
- Angle-closure glaucoma
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Cardiac arrhythmia
- Chronic myocardial ischemia
- Diabetes mellitus
- Hypertension
- Seizure disorder
- Severe renal impairment
- Thyrotoxicosis
- Urinary retention
UTIBRON NEOHALER (indacaterol maleate/glycopyrrolate)
- Bronchospasm prevention with COPD
- Prevention of bronchospasm with chronic bronchitis
- Prevention of bronchospasms with emphysema
- Pharyngitis
- Cough
- Headache disorder
- Hypertension
- Upper respiratory infection
More Frequent
Severe
Less Severe
- Chest pain
- Diabetes mellitus
- Sinusitis
- Arthralgias
- Back pain
- Bronchitis
- Cramps
- Diarrhea
- Dizziness
- Dyspnea
- Fatigue
- Insomnia
- Muscle spasm
- Myalgias
- Nausea
- Peripheral edema
- Pharyngitis
- Pneumonia
- Rhinitis
- Sinusitis
- Skin rash
- Sore throat
- Upper respiratory infection
- Urinary retention
- Urinary tract infection
- Wheezing
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Aggravated glaucoma
- Angina
- Angioedema
- Asthma exacerbation
- Atrial fibrillation
- Cardiac arrhythmia
- Diabetes mellitus
- Gastroenteritis
- Hyperglycemia
- Hypokalemia
- Paradoxical bronchospasm
- Pneumonia
- Skin rash
- Tachycardia
Less Severe
- Cough
- Dyspepsia
- Dysuria
- Hyperglycemia
- Insomnia
- Limb pain
- Nausea
- Palpitations
- Pruritus of skin
- Upper abdominal pain
- Voice change
Contraindicated
None
Severe Precaution
Glycopyrrolate (Inhalation)
Safety and efficacy not established. Not indicated in pediatrics.
No safety and efficacy established. Not indicated for asthma.
- 1 Day – 18 Years
- Safety and efficacy not established. Not indicated in pediatrics.
Indacaterol
Safety and efficacy not established. Not indicated in pediatrics.
No safety and efficacy established. Not indicated for asthma.
- 1 Day – 18 Years
- No safety and efficacy established. Not indicated for asthma.
Management or Monitoring Precaution
None
Glycopyrrolate
- Severity Level:
2
- Additional Notes: Insuff human data avail; animal data do not sug risk
Indacaterol
- Severity Level:
C
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Glycopyrrolate
May inhibit lactation; unlikely to be excreted.
Insufficient human data, excreted in rats
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | May inhibit lactation; unlikely to be excreted. |
Indacaterol
May inhibit lactation; unlikely to be excreted.
Insufficient human data, excreted in rats
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data, excreted in rats |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- One ingredient in this product is indacaterol. It belongs to the class of drugs known as long-acting beta agonists (LABAs). Rarely, people with asthma who use LABA medications have had serious (sometimes fatal) asthma-related breathing problems. Indacaterol/glycopyrrolate is not approved to treat asthma.
| Bronchospasm prevention with COPD | |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| Prevention of bronchospasm with chronic bronchitis | |
| J41 | Simple and mucopurulent chronic bronchitis |
| J41.0 | Simple chronic bronchitis |
| J41.1 | Mucopurulent chronic bronchitis |
| J41.8 | Mixed simple and mucopurulent chronic bronchitis |
| J42 | Unspecified chronic bronchitis |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| Prevention of bronchospasms with emphysema | |
| J43 | Emphysema |
| J43.0 | Unilateral pulmonary emphysema [macleod's syndrome] |
| J43.1 | Panlobular emphysema |
| J43.2 | Centrilobular emphysema |
| J43.8 | Other emphysema |
| J43.9 | Emphysema, unspecified |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| 0-9 | A-Z |
|---|---|
| J41 | Simple and mucopurulent chronic bronchitis |
| J41.0 | Simple chronic bronchitis |
| J41.1 | Mucopurulent chronic bronchitis |
| J41.8 | Mixed simple and mucopurulent chronic bronchitis |
| J42 | Unspecified chronic bronchitis |
| J43 | Emphysema |
| J43.0 | Unilateral pulmonary emphysema [macleod's syndrome] |
| J43.1 | Panlobular emphysema |
| J43.2 | Centrilobular emphysema |
| J43.8 | Other emphysema |
| J43.9 | Emphysema, unspecified |
| J44 | Other chronic obstructive pulmonary disease |
| J44 | Other chronic obstructive pulmonary disease |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
Formulary Reference Tool